Panama buying Cannabis

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Panama buying Cannabis

Multinational transactions are common for ANKIP, which, at the request of its clients, has increased its size and areas of practice to include labour, migration, civil law, arbitration and the protection of generational wealth transfers. Panama is on track to legally sell its first medical cannabis product before the end of , and as with all new markets, a frenzy of preparation is hectically underway. Taking the wait-and-see approach has permitted Panama to incorporate concepts from neighboring countries while staying faithful to its strategic geographical advantages, carefully considering and regulating the use of medical cannabis in and from Panama. The next 24 months will be critical in determining whether Panama embraces or squanders this opportunity. Products containing synthetic THC of any type are not considered medical cannabis, and are prohibited. Although many other decrees, resolutions and similar relate to this industry, this article will only concentrate on the most important laws and regulations — namely, Law and Decree Navigating through new laws that have zero jurisprudence can seem complicated — the following is therefore a simplified breakdown:. The reader should not think that this industry is lax in Panama; on the contrary, the regulations are aimed at ensuring that medical cannabis is not used recreationally. Panama has approved the investigation, production, transformation, importation, exportation, re-exportation and domestic sale of medical cannabis for consumption in Panama and internationally, in all its current forms, with one gray area: vapes. See more regarding vapes in 1. Consumption of medical cannabis is limited to patients who hold a valid prescription issued by a trained medic. The growing and transforming of cannabis in Panama has been regulated with two main objectives in mind: quality and control. Any medical cannabis produced in Panama will need to meet good manufacturing practice GMP standards, and all fabrication licensees must ensure that their operations are compliant with modern GMP guidelines. Several regulatory bodies are entrusted with powers to inspect and verify strict compliance with quality standards. Similar GMP guidelines apply for the transformation of flower cannabis into other products, such as edibles, creams, pills and so forth. Every plant is traced from seed to harvest, and every product inventoried per piece or weight. CCTV systems with face-recognition software are a requirement in every room that produces, processes, stores, transports or sells a medical cannabis product, including dispensaries. Transporting medical cannabis in Panama requires closed and tagged parcels; each parcel must have a GPS tracking device, as must each car that transports the parcel s. A manifesto must accompany each transportation of medical cannabis in Panama. All the forgoing is subject to review and inspection by the regulatory authorities. International commerce of medical cannabis is tightly controlled, and is only approved as business-to-business — meaning that a licensee from Panama can only purchase from, or sell to, a licensee from another country. Wholesale medical cannabis can only be purchased in Panama by fabrication licence holders selling among licensees and pharmacies that have a licence to sell controlled substances. The prescription can be valid for a maximum period of 90 days, and patients will need to register in the National Medical Cannabis Registry and validate their prescriptions. Inclusion in the Registry must be renewed yearly. When prescriptions are fulfilled in a pharmacy or dispensary, the purchase must be registered in the Registry prior to handing the medical cannabis to the patient. The National Medical Cannabis Registry is constantly synchronised and updated, meaning it will guarantee that a patient cannot purchase more medical cannabis than has been prescribed to them. Pharmacies, hospitals and dispensaries must retain a copy on file of each prescription they fulfilled, either completely or partially, and are obligated to hold the copy on file for five years. Doctors can participate after they have undertaken the mandatory training course offered by a MINSA-approved training entity. Licensees can also participate. Law specifies two types of available licence for medical cannabis in Panama, as follows. This is free and is given after the employment candidate provides the following:. This Labour Code ID must be renewed every two years, and a similar approval process is imposed for other industries, such as casinos. Every person involved in an application for a fabrication licence had to provide a clean criminal record and proof of identity, and pass an extensive background check under the scrutiny of the Ministry of Security. Regarding the strategic international partner, each fabrication licensee must have an experienced partner from a country that legally sells medical cannabis. This partner oversees supplying the know-how, and in some cases the financial backing, of the Panamanian fabrication licensee. Some consider this a third type of licence, while others see it as more of a database of approved suppliers. Training entities can be any public or private, natural or legal person. There is currently no limit regarding a specific number of entities, and such entities are entrusted with training:. Every course is different; each complete course must be at least six hours, and no course can be held virtually. Fabrication licensees can sell wholesale to pharmacies, hospitals and other licensees. They can also distribute on a retail level through their own dispensaries. If all boxes are checked during the inspection and following full compliance, the licensee will be permitted to pay the governmental licensee fee of USD, — after which, the government will issue their licence, valid for ten years. During the first 24 months of each licence, the licensee will be permitted to import any medical cannabis product from any international supplier, conditional on the supplier being an authorised medical cannabis seller in their home country. This month period is permitted so that licensees can promptly accomplish local supply of medical cannabis and satisfy the local medical cannabis market in Panama. After these initial 24 months, all medical cannabis products that are sold in Panama must be produced in Panama. After the initial ten years, if a fabrication licensee is interested in extending their licence, they must request such an extension. Currently, there is no confirmed date for when medical cannabis will be available for sale in Panama, as no licences have yet been issued. Based on current local trends, the authors estimate that the first licensees will be operational before the end of For more detail on this, see 1. The matter of where medical cannabis can be sold in Panama is simple — ie, anywhere where controlled substances can be sold, either business-to-business or retail. Pharmacies, hospitals and licensees are approved for selling medical cannabis. Doctors cannot sell medical cannabis nor prescribe a specific brand. Delivery via commercial couriers is strictly forbidden; however, patients that cannot fulfil their prescription personally may empower one person at a time to do so on their behalf. Only controlled and pre-approved areas such as greenhouses or warehouses are authorised to grow cannabis in Panama. Cultivation sites must be approved by the Ministry of Agriculture and the Ministry of Security. If a fabrication licensee intends to re-export medical cannabis, they must be located in a tax-free zone and in a pre-approved location. Regarding consumption of medical cannabis in Panama, use is intended to be private. Consumption in public spaces such as roads, parks, restaurants, theatres, clubs and similar is prohibited. In the workplace, if an employer approves the use of medical cannabis on their property and has a designated area for such use, the patient may consume their medical cannabis at work. Decree applies most importantly to local government — ie, concerning how to control. Decree regulates how every medical cannabis product is grown, imported, produced, exported, sold or investigated in Panama. It regulates:. The complexities of these regulatory bodies and how they interact with the System, both among themselves and among licensees, is discussed in 1. Law and Decree mandate six regulatory bodies to directly and actively oversee the medical cannabis industry; an additional three regulatory bodies are involved, but in a more passive form. MINSA is the governing body that supervises and regulates all health-related issues involving humans, including for hospitals, protocols, vaccines, medicines, nurses and pharmacies. MINSEG is the governing body that supervises and regulates all security-related issues, such as regarding the police, border patrol, naval services, immigration, illegal drugs and all things related to firearms. The security standards imposed on every licensee are stringent, and include the following among others :. MIDA is the governing body that supervises and regulates all issues related to the national food supply, national agriculture and farm animals, including veterinaries and the products they use. It also supervises, approves and regulates all the tax-free commercial zones in the country; these tax-free commercial zones are similar to huge, bounded warehouses, with some the size of small cities. MEF has one specific role to play in this industry: approving the incorporation of a licensee into a tax-free commercial zone. Decree specifically indicates that only fabrication licensees that are established in a tax-free zone can re-export medical cannabis products. This includes data security related to patient confidentiality and rights, System and Registry availability, maintenance and so forth. These three more passive governing bodies oversee the medical cannabis industry, similar to how they oversee almost all national industries, with one exception: fabrication licensees can expect additional scrutiny at least initially. Four groups, including the industry guild, deserve special mention and are listed in the chronological order in which they became active in promoting medical cannabis. Founded by Panamanian-born epilepsy specialists, renowned worldwide as leaders in their field, this non-profit foundation has one aim: to assist epilepsy patients in overcoming their illness through education and innovative treatments. The Foundation was the pioneer in medical cannabis legislation in Panama, and was instrumental in finally obtaining approval for legislation. It provided doctors with time to meet with governmental authorities, elected officials, lawyers and of course patients. The reputable board of directors of this Foundation was key in capturing the attention of three different Panamanian Presidents, three distinct legislative branches and hundreds of doubtful local doctors. The Foundation has the support of several patient associations, local celebrities and a wide array of doctors, and, through continuous educational efforts combined with real case success, has even managed to apply enough pressure for cannabis to be considered as a viable alternative medicine for patients. The Foundation has now been actively involved in the medical cannabis legislative process in Panama for almost ten years, and is expected to remain involved once the industry starts operating. ANPEMUFA, composed mainly of patients and their families with the support of national and international doctors, has also invested time and effort in explaining to uninformed doctors, lawyers and government officials the need for regulating medical cannabis. More importantly, it has shown that many patients report better and faster results from using cannabis than from using certain pharmaceutical products. Panama does not have a Bar Association as in other countries — the closest thing is the CNA, which is a non-profit union of lawyers. The CNA is commonly called on for advice by lawmakers and private citizens, and assists with fine-tuning legislation and forecasting difficulties in applying laws. Any work done by a lawyer for the CNA is pro bono. This Commission has two main goals:. This organisation is agreed upon but not yet formed. The seven fabrication licensees have agreed on forming a guild that aims to guarantee three things: quality, supply and compliance. A common worry among the seven licensees is that one or more of them will commit an offence by design or by mistake such as faltering in compliance, erring in reporting, supplying low-quality products, or worse. As medical cannabis is new and heavily regulated in Panama, the potential mistakes of one licensee undoubtedly affect the other six. Licensees cannot market their products in Panama and are only allowed to promote medical cannabis through education of the population, including doctors. For this reason, particular effort is being put into promptly training local doctors and reducing the historical stigma that exists in Panama related to cannabis. Doctors may shy from prescribing cannabis if negative media constantly circulates in Panama regarding the misuse of medical cannabis, or regarding mistakes by the new licensees. The most notable challenge that market participants currently face — and will continue to face for the near future — is uncertainty. What is agreed upon by most international industry participants is that medical cannabis vape pens are here to stay. On 30 June , Panama published Law , which aims at educating the general population on the hazards of e-cigs and similar products. At the same time, Law prohibits the use or sale of electronic equipment such e-cigs, vaporisers, tobacco heating systems and similar products in Panama. Law does not differentiate between nicotine-containing products and non-nicotine-containing products — no distinction is made between a vape device designed for tobacco and one for cannabis. Smoking is prohibited in restaurants, casinos, concerts or public spaces in Panama. This means that, in a visit to Panama lasting a full week, one would probably only see one or two people per day smoking a cigarette. Panamanians are thus not accustomed to seeing people smoke in public, nor are they used to the smell of burnt tobacco in their midst. Smelling cannabis smoke, or seeing a patient smoke cannabis anywhere, would immediately draw the attention of passersby. As patients have enough difficulties to deal with, adding further stigma to their treatment is not beneficial. The solution for many patients is medical cannabis vapes. The immediate discrete dosage thereof, with practically no accompanying smell, helps to maintain patient privacy. The legality of the use of medical cannabis vapes in Panama is controversial. Those against vapes point to Law of , which is very clear regarding the prohibitions of vapes in Panama. However, what happens if a specialist prescribes that medical cannabis should be delivered by vape pen instead of by an edible or smokable? This uncertainty will likely reveal itself in the court system over the next few months. The local Constitution prohibits a central bank or the issuance of paper currency. In short, using bills in Panama means using US dollar bills. When one transfers money into or out of Panama, this is done in US currency. Most are Panamanian or regional banks, six are international banks and two are national, government-owned banks. The exact same issues that are affecting the cannabis industry in the USA are affecting the industry in Panama. If a correspondent bank in the USA is unwilling to open an account for a dispensary in California or Boston, they are much less willing to allow a Panamanian bank to use them to transfer proceeds from medical cannabis to or from Panama. The two government-owned banks, Banco Nacional and Caja del Ahorro , are in a complicated position; Panama has no federal system, so the government that charges licensees for their licence fee is the same government that owns the banks. That said, the uncertainty here pertains to why a government-owned bank would not open a bank account for a company that holds a government-issued medical cannabis licence, and whether private banks would do so. Running a cash-only medical cannabis enterprise in Panama is complicated, costly, risky and a compliance nightmare for all involved. Similar to banks, insurance companies are very cautious when considering medical cannabis. Patients that require very specific strains of medical cannabis normally with THC under 1. In a country where the monthly minimum salary is around USD per month, the need for public or private medical insurance to cover this medication cost is understandable. Law also allows pharmaceutical companies that donate their products directly to patients to deduct the cost of these products from their income tax; however, Decree prohibits the donation of medical cannabis. Will public or private insurance companies cover medical cannabis prescriptions? Will local suppliers be permitted to donate part of their production to patients in need? Eliminating these uncertainties will help patients who require medical cannabis and who cannot sustain the monthly costs of medication. As noted in 1. This causes uncertainty, and creates the risk of non-compliance due to error rather than ill will. The System — which is fundamental — has not yet been acquired by the Panamanian government, much less installed, tested or taught to regulators or to those being regulated. The laboratories meant to verify the quality of products produced in or sold in Panama have yet to receive their operating licences. The training entities meant to train medics, industry employees and the police have yet to be chosen or contracted for, and the course material has not been circulated in the industry. MIDA has not yet established a protocol for the importation of cannabis seeds, nor for the growing of cannabis in Panama. MINSA has yet to circulate the protocols to be followed in cases of visitors or expats in Panama — ie, can visitors purchase medical cannabis, if prescribed? Training of the police force has not been completed, leading to the question of what would happen were a first patient to be stopped during a routine traffic stop and medical cannabis found in their possession. Panama has a very strict, non-lenient policy regarding narcotics; educating police and changing their perspective — ie, in understanding that a patient is not the same as a recreational user — will be paramount for eliminating the current stigma and preventing discomfort among patients. Based on previous uncertainties, it must be concluded that, even if all seven licences were to be issued tomorrow, Panama would still not be able to supply its patients for several more months or possibly even years. All the above should, under normal circumstances, be part of a well-developed business plan; however, this is impossible owing to uncertainty regarding when sales will be available. Although local authorities are working diligently to cut delay times, no business can plan without a calendar and clear dates on hand. A smooth sea never made a skilled sailor — Panama may require some life jackets as the water ahead appears turbulent. Overnight, the overwhelming majority of Panamanian banks decided to unilaterally stop working with American citizens. Accounts were closed and new accounts were rejected. However, the reasons for this were not based on anti-American sentiment or anything similar. The banks, although wanting to comply, did not know how to, and feared that an omission due to lack of clarity would entail fines or worse and accusations that they were assisting US citizens in evading US laws. Overnight, a simple solution was devised: to cease all work with American citizens unless the transactions were financially large enough to merit such risk. Today, the cannabis industry in Panama is very similar. There is a common fear among all licence holders; they all claim to be investing heavily in compliance, and want to ensure complete adherence to local norms and regulations. They all fear that, due to the volume, overlapping nature and complexity of laws, they will falter in some technicality and be fined or even prosecuted. Law and Decree both provide a long list of monetary sanctions that can be imposed on licensees if they falter, though this also leaves the door open for criminal investigations. Panama switched criminal systems in late, eliminating the previous inquisitorial criminal system and implementing a new accusatory criminal system. Previously, defendants had the right to try and prove their innocence; now they are presumed innocent until proven guilty. The system changed, but not necessarily the people in it. Many prosecutors hail from the old system, were trained in that system, worked inside that system for 20 years and today still hold positions of importance in the new system. This is relevant to medical cannabis as, if one uninformed and uneducated prosecutor decides to open an investigation into a licensee with zero evidence of wrongdoing, that licensee will be under a microscope until the investigation is closed due to lack of evidence, or until victory in court. Training prosecutors should be as important as training industry employees, as both can have an adverse effect on the industry. Panama has an abundance of anti-money laundering regulations. Every company in Panama that receives over USD10, in cash in a transaction needs to report that transaction to a specialised government agency. Requiring the cannabis industry to operate without banks is counterproductive. How can Panama enforce all the positive and well-intended anti-money laundering regulations while requiring licensees to work only in cash? Such amounts of cash pose a security risk — licensees would not wish to have such amounts on hand or face the problem of its secure storage. Compliance with anti-money laundering regulations is difficult if licensees cannot use digital cash services, credit cards and banks in general. Non-compliance with anti-money laundering laws is a criminal offence that leads to a money laundering investigation. It is a vicious cycle with no proposed exit route. MINSA is the main regulatory body and, as such, the institution with the most oversight and penalty-imposing powers. MINSA can impose three types of penalties, for minor infractions, major infractions and severe infractions. There are currently a dozen minor infractions, including:. There are currently 29 major infractions, including:. There are currently eight severe infractions, including:. MIDA can apply penalties on a licensee, and specifically as regards the cultivation division of their operation. Hence, MIDA is in charge of ensuring that:. MIDA also supervises the complete cultivation process from seed to flower. MIDA can impose penalties, but no distinction is made between penalties applied to fruits and vegetables grown in Panama and those applied to medical cannabis. MINSA and MIDA are entrusted with compliance and with applying monetary penalties and possibly licence suspensions in the case of lax compliance by licensees. MINSEG oversees the security compliance of each medical cannabis product sold in Panama, including verifying traceability. MINSA may impose a fine on a licensee for dispensing medical cannabis to a person without a prescription — this is also a criminal offence in Panama, so the offender may incur a monetary fine as well as potential personal liberty restrictions. Panama requires that all local licensees work only with valid licensees from other countries. A licensee in Panama can purchase products from a supplier anywhere in the world, solely conditional on the supplier being licensed to sell medical cannabis in their home country. The same applies as regards selling medical cannabis from Panama to other countries; local licensees are free to sell to any country in the world provided their client is authorised by their home country to purchase medical cannabis. Any transaction involving Panama and the importation or exportation of medical cannabis will need to be declared and validated by Panama and the partner country, prior to any products arriving in or leaving Panama. These overlapping responsibilities can lead to repetitive reporting, an increase in paperwork and confusion regarding to whom a licensee must report. For example, when hiring an industry employee at any level, the potential employee must first obtain a Labour Code ID from the Labour Ministry, before completing a course with a certified training entity. If the employee works in the cultivation section of the business, they must also be registered with MIDA. Several legal elements affect access to medical cannabis in Panama, all of which should be resolved during The System, including the National Patient Registry, is not yet operational. Even if a licensee had the products to supply the market today, they would be unable to due to inability to register their inventory; and it would be unclear how they would register prescriptions or present their monthly reports. The National Patient Registry, a module of the System, is also not yet operational — meaning that there are no approved patients for medical cannabis, and indicating that even if the product were available it would still be illegal to dispense. Pharmacists must complete a training course prior to being approved to fulfil a medical cannabis prescription. To date, MINSA has yet to inform the public of the content of these training courses, their duration, and whether they will be virtual or not. Currently, there is also lack of clarity regarding which companies will undergo such training. With the content of the training courses yet to be determined, and with those companies that will train local experts and employees still not decided on, completing obligatory training is not an achievable goal. An important number of patients will receive prescriptions that will be too expensive for them to fulfil without making use of medical insurance. Will the public healthcare system supply cannabis? Will private medical insurance companies cover medical cannabis? There are simply no answers yet. While certain laws do specifically mandate both public and private medical insurance companies to cover all expenses of patients suffering from rare diseases, there is still lack of clarity regarding what happens in the case of patients suffering from other illnesses that are more frequent than for one in 2, people. Another question concerns who decides whether cannabis is the correct medicine for a patient. This means that, in theory, private insurance companies should cover medical cannabis — though in practice this remains to be seen. In the case of bedridden patients, limited-mobility patients or patients in palliative care, if a doctor prescribes medical cannabis, the patient cannot go to a pharmacy or dispensary to fulfil the prescription. The patient can send a person to do this for them; however, that person must be registered in the National Patient Registry and be approved by MINSEG after presenting a clean criminal record, which can prove troublesome. Nonetheless, this does not mean an open season for CBD in Panama. Currently, there is no legal move or legislative appetite for decriminalising cannabis in Panama, much less for promoting its recreational use. If and when a rescheduling of the classification of cannabis is approved by the US Drug Enforcement Agency, Panama may feel persuaded to follow suit. Chambers and Partners website Toggle navigation. Last Updated May 30, Law and Practice. Expand All. Regulatory Framework. How Did Panama Get Here? The following are prohibited. Beverages that combine alcohol and cannabis. The only exception to this applies to beverages that use alcohol as a solvent. Medical cannabis produced in attention-grabbing shapes — ie, no cannabis products in the shapes of animals, people, fruits or any other shape that may draw the attention of minors. Using cannabis in food destined for human consumption. The only exception to this applies to medical cannabis edibles. None is allowed — ie, not online nor on traditional channels. The only exception to this is educational material that does not directly promote the sale of any specific product, brand or strain. Who can purchase? In brief, patients and medical establishments including pharmacies can purchase. The retail purchase of medical cannabis is limited to patients with a valid prescription. Who can participate? Fabrication licence: holders of this licence are authorised to produce, transform, import, export, re-export and domestically sell medical cannabis. Investigation licence: holders of this licence cannot commercialise medical cannabis in any of its forms; such licensees can only use cannabis for investigative purposes. This licence is aimed at universities, regional investigation centres and laboratories located in Panama, and that will certify the quality, THC and CBD content, and other requirements regarding medical cannabis produced in Panama. As a requisite of the MINSA licence-awarding process, all 16 fabrication licence applicants had to: fully disclose their corporate structure, shareholders and financial capacities; list their board of directors; and list their strategic international partner. There is currently no limit regarding a specific number of entities, and such entities are entrusted with training: doctors on the use of medical cannabis for patients; pharmacists and dispensary personnel; and licensee employees. Who can sell? Pharmacies, hospitals and dispensaries can only sell medical cannabis at a retail level. Decree Decree applies most importantly to local government — ie, concerning how to control. It regulates: how software systems operate and who administers them; and how licensees are subject to a surveillance system and to supervision by regulatory bodies. These sometimes-overlapping regulatory bodies are discussed further below. Ministry of Health MINSA MINSA is the governing body that supervises and regulates all health-related issues involving humans, including for hospitals, protocols, vaccines, medicines, nurses and pharmacies. Ministry of Security MINSEG MINSEG is the governing body that supervises and regulates all security-related issues, such as regarding the police, border patrol, naval services, immigration, illegal drugs and all things related to firearms. The security standards imposed on every licensee are stringent, and include the following among others : all entries and exits of places where cannabis is stored must have interior and exterior cameras; all areas where medical cannabis is weighed, packed, transported or labelled must have cameras; one camera must be in place specifically for the entry into secure areas of buildings where medical cannabis is stored; all cameras must be high-resolution, so that employees and the products they manipulate can be easily identifiable; cameras must be able to record the facial features of all that enter a place where medical cannabis is stored — this includes patients, visitors, employees, etc; industry employees must be vetted prior to being hired; and GPS tracking of all medical cannabis products must be in place, including for plants. Ministry of Agriculture MIDA MIDA is the governing body that supervises and regulates all issues related to the national food supply, national agriculture and farm animals, including veterinaries and the products they use. Medical Cannabis Guild This organisation is agreed upon but not yet formed. This means that no vapes can be legally sold in Panama, nor can they be used in public spaces. Insurance Uncertainty Similar to banks, insurance companies are very cautious when considering medical cannabis. Bureaucratic Uncertainty As noted in 1. Calendar Uncertainty Based on previous uncertainties, it must be concluded that, even if all seven licences were to be issued tomorrow, Panama would still not be able to supply its patients for several more months or possibly even years. Currently, local industry participants cannot: plan their cultivation cycles; reserve ready-to-ship products from overseas suppliers; import machinery needed in the industry; hire employees as they are not yet trained ; or lease commercial space for dispensaries. Criminal System Panama switched criminal systems in late, eliminating the previous inquisitorial criminal system and implementing a new accusatory criminal system. Anti-money Laundering Regulations Panama has an abundance of anti-money laundering regulations. A final penalty amount to be imposed is decided by MINSA, after considering: the damage done by the infraction; the benefits obtained from the infraction; whether the infraction was intentional or negligent; and whether the licensee had previously committed the same infraction. Hence, MIDA is in charge of ensuring that: no harmful chemicals are used; only approved seeds are used; and agricultural GMPs are strictly followed. Cross-Jurisdictional Matters. Legal and Regulatory Developments. Training Entities Are Not Themselves Trained Doctors must undertake a course prior to being certified to prescribe medical cannabis. Insurance Coverage An important number of patients will receive prescriptions that will be too expensive for them to fulfil without making use of medical insurance. Prescription Fulfilment by Third Parties In the case of bedridden patients, limited-mobility patients or patients in palliative care, if a doctor prescribes medical cannabis, the patient cannot go to a pharmacy or dispensary to fulfil the prescription. Law and Practice Author. Select Topic s. Please select at least one chapter and one topic to use the compare functionality. Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website.

Medical Cannabis & Cannabinoid Regulation 2024

Panama buying Cannabis

Emma Stone. In doing so, Panama became the first Central American country to legalize medical marijuana. Recreational marijuana use, however, remains illegal in Panama. Panama has already issued regulations regarding who will be eligible to receive medical marijuana treatment. Each patient record will be documented in the registry , with details regarding their condition, the treating physician, the prescribed cannabis dose, and the frequency of treatment. Patients will only be able to access medical marijuana products from licensed pharmacies. The Panamanian government has also released another decree focused on the secure management of medicinal cannabis. The Directorate is responsible for supervising the production, cultivation, handling, storage, and transport of medical marijuana products in Panama. It is also responsible for issuing licenses for medical cannabis producers and outlining the security protocols for those who will be cultivating or producing medical cannabis products. When transport ships transit through the Panama Canal, they can avoid circumnavigating the tip of Latin America. This makes Panama an attractive prospect for cartel activity and narcotics trafficking. With medical marijuana now legal in Panama, this technically should render it easier for cannabis to be shipped through the Canal. Illegal shipments of marijuana or other drugs are frequently seized in Panama. Allowing shipments of cannabis through the Panama Canal could influence global cannabis supply chains. Panama plans to welcome both local and foreign companies that can supply Panamanians with cannabis products created using raw materials produced in Panama. Cohen has also invited research centers, universities, and institutes specializing in medical cannabis to conduct clinical trials. Panama has been celebrated as a trailblazer in the region as the first Central American country to legalize medical marijuana, with Costa Rica following suit several months afterward. Medicinal cannabis cultivation is now allowed in Panama thanks to the executive decree enacted in Licenses will be issued by the Ministry of Security, with the Ministry of Agricultural Development, National Customs Authority, and the Ministry of Commerce and Industries responsible for keeping an eye on businesses growing cannabis. Panama made headlines in when it became the first Central American country to legalize marijuana for medicinal use. The country is fast implementing the rollout of its cannabis program for qualifying patients and businesses that wish to set up cannabis operations. Article written by Emma Stone.

Panama buying Cannabis